Thermo Fisher Scientific Inc. (NYSE:TMO) TD Cowen 44th Annual Health Care Conference March 6, 2024 9:10 AM ET Company Participants Marc Casper - Chairman, President and CEO Conference Call Participants Dan Brennan - TD Cowen Dan Brennan Great. Welcome, Day 3 of the TD Cowen Global Healthcare Conference, 44th Annual. I'm Dan Brennan, I cover tools, diagnostics here. Really pleased to be joined with me on stage here, Marc Casper, Chairman, President and CEO of Thermo Fisher. So, Marc, welcome. Marc Casper Tha ...

A month has gone by since the last earnings report for Thermo Fisher Scientific (TMO) . Shares have added about 3.3% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Thermo Fisher due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Thermo Fisher Q4 Earnings Top Estimat ...

Thermo Fisher Scientific (TMO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this maker of scientific instrument and laboratory supplies have returned +3.3% over the past month versus the Zacks S&P 500 composite's +5.2% change. The Zacks Medical - Instruments industry, to which Thermo Fisher belongs, has gained 4.9% over this period. Now the key questio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number 1-8002 THERMO FISHER SCIENTIFIC INC. (Exact name of Registrant as specified in its charter) Delaware 04-2209186 (State of incorporation) (I.R.S. Employer Identification No.) 168 Thir ...

Thermo Fisher Scientific, Inc. (TMO) recently introduced a new instrument for Ion chromatography to enhance labs' functional adaptability, efficiency, and reliability -- Thermo Scientific Dionex Inuvion Ion Chromatography (IC) system. The new system will make ion analysis simpler and more intuitive for labs of all sizes.The recent launch will bolster Thermo Fisher’s Analytical Instrument segment.More on New LaunchThe Dionex Inuvion system helps labs operate more effectively by providing simply adjustable wo ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

Thermo Fisher Scientific (TMO) continues to gain from strategic partnerships. Yet, macroeconomic issues dent growth. The company carries a Zacks Rank #3 (Hold) currently.Within the pharma and biotech end market, of late, Thermo Fisher’s biosciences and bioproduction businesses have significantly expanded their capacity to meet the global vaccine manufacturing requirements. Additionally, the pharma services business has been providing pharma and biotech customers with the services they need to develop and pr ...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2023 Earnings Conference Call January 31, 2024 8:30 AM ET Company Participants Rafael Tejada - VP of IR Stephen Williamson - SVP and CFO Daniel Arias - Stifel, Nicolaus & Company Derik De Bruin - Bank of America Operator Good morning, and thank you for joining us. On the call with me today is, Marc Casper, our Chairman, President and Chief Executive Officer; and Stephen Williamson, Senior Vice President and Chief Financial Officer. Please note this call is being w ...

For the quarter ended December 2023, Thermo Fisher Scientific (TMO) reported revenue of $10.89 billion, down 4.9% over the same period last year. EPS came in at $5.67, compared to $5.40 in the year-ago quarter.The reported revenue represents a surprise of +1.40% over the Zacks Consensus Estimate of $10.74 billion. With the consensus EPS estimate being $5.64, the EPS surprise was +0.53%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.67 per share, beating the Zacks Consensus Estimate of $5.64 per share. This compares to earnings of $5.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.53%. A quarter ago, it was expected that this maker of scientific instrument and laboratory supplies would post earnings of $5.58 per share when it actually produced earnings of $5.69, delivering a surpri ...